NCT02056015View on ClinicalTrials.gov

A Phase I Study of MLN6907 in Patients With Metastatic Colorectal

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Imaging of Solid Gastrointestinal Tumors
Interventions
DRUG

[68Ga]MLN6907

IV Administration of \[68Ga\]MLN6907 on Day 1

Trial Locations (2)

Unknown

Iowa City

Alburquerque

Sponsors
All Listed Sponsors
lead

Millennium Pharmaceuticals, Inc.

INDUSTRY